Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
OtherArticle

Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease

Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, James Ranger-Moore, Jonathan P. Jackson, Stephen S. Ferguson and Nathan J. Cherrington
Drug Metabolism and Disposition October 2009, 37 (10) 2087-2094; DOI: https://doi.org/10.1124/dmd.109.027466
Craig D. Fisher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J. Lickteig
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa M. Augustine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Ranger-Moore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan P. Jackson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen S. Ferguson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan J. Cherrington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 37 no. 10 2087-2094
DOI 
https://doi.org/10.1124/dmd.109.027466
PubMed 
19651758

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received March 22, 2009
  • Accepted July 27, 2009
  • Published online September 18, 2009.

Article Versions

  • Earlier version (August 3, 2009 - 07:49).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2009 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Craig D. Fisher,
  2. Andrew J. Lickteig,
  3. Lisa M. Augustine,
  4. James Ranger-Moore,
  5. Jonathan P. Jackson,
  6. Stephen S. Ferguson and
  7. Nathan J. Cherrington
  1. Department of Pharmacology and Toxicology (C.D.F., A.J.L., L.M.A., N.J.C.) and
  2. Division of Epidemiology and Biostatistics (J.R.-M.), University of Arizona, Tucson, Arizona;
  3. CellzDirect, Inc., Austin, Texas (J.P.J.); and
  4. Cellz Direct, Inc., Durham, North Carolina (S.S.F.)
  1. Address correspondence to:
    Nathan J. Cherrington, Department of Pharmacology and Toxicology, 1703 E. Mabel Street, Tucson, AZ 85721. E-mail: cherrington{at}pharmacy.arizona.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2009 to May 2022

AbstractFullPdf
Aug 2009970231
Sep 200914515155
Oct 20091572955
Nov 2009702777
Dec 2009661151
Jan 20101082830
Feb 2010671732
Mar 2010582826
Apr 2010522316
May 2010892320
Jun 2010533024
Jul 2010421614
Aug 2010492316
Sep 201065118
Oct 2010513427
Nov 2010302734
Dec 2010242827
Jan 2011183332
Feb 2011252747
Mar 2011444930
Apr 2011224349
May 2011202933
Jun 2011223131
Jul 2011212233
Aug 2011202223
Sep 2011373741
Oct 2011274346
Nov 2011333426
Dec 2011332834
Jan 2012343137
Feb 2012535644
Mar 2012513839
Apr 2012554641
May 2012355434
Jun 2012213834
Jul 2012372827
Aug 2012164231
Sep 2012203028
Oct 2012303637
Nov 2012393558
Dec 2012232919
Jan 2013405538
Feb 2013365840
Mar 2013264353
Apr 2013273735
May 2013523744
Jun 2013152214
Jul 2013252612
Aug 2013162422
Sep 2013402511
Oct 2013192313
Nov 2013224223
Dec 2013211311
Jan 2014223526
Feb 2014303819
Mar 2014233419
Apr 2014222315
May 2014413729
Jun 2014211814
Jul 2014224024
Aug 2014122412
Sep 2014103117
Oct 2014184415
Nov 2014101910
Dec 201415349
Jan 2015213622
Feb 2015202922
Mar 2015343013
Apr 2015252153
May 2015252515
Jun 2015273621
Jul 2015182021
Aug 2015301515
Sep 2015192321
Oct 2015211318
Nov 2015122122
Dec 2015231618
Jan 2016233228
Feb 2016211923
Mar 2016311629
Apr 2016293331
May 2016171828
Jun 2016172420
Jul 201612268
Aug 2016212126
Sep 2016182212
Oct 2016133719
Nov 2016123318
Dec 2016103118
Jan 20173349
Feb 201723710
Mar 201734128
Apr 201793417
May 201774317
Jun 201772513
Jul 201792313
Aug 2017114426
Sep 201754219
Oct 201755723
Nov 201757021
Dec 201763027
Jan 201895826
Feb 201810328
Mar 2018106024
Apr 2018163920
May 201828520
Jun 201847829
Jul 201806327
Aug 201824024
Sep 201804122
Oct 201808933
Nov 2018010934
Dec 2018822111
Jan 20198007
Feb 201993613
Mar 201972710
Apr 201962819
May 201945107
Jun 201941214
Jul 201942913
Aug 201962913
Sep 20196047
Oct 20194424
Nov 2019571311
Dec 20195576
Jan 20202966
Feb 20202925
Mar 20205865
Apr 2020581212
May 20207257
Jun 20207285
Jul 20204153
Aug 20202855
Sep 20204778
Oct 202057217
Nov 202043134
Dec 20205154
Jan 2021632313
Feb 2021562814
Mar 2021721113
Apr 202178813
May 202170126
Jun 202165129
Jul 20215297
Aug 2021652111
Sep 202145129
Oct 2021601310
Nov 202146816
Dec 2021821011
Jan 20221161214
Feb 2022621012
Mar 2022601714
Apr 2022641510
May 20224947

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 37 (10)
Drug Metabolism and Disposition
Vol. 37, Issue 10
October 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
OtherArticle

Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease

Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, James Ranger-Moore, Jonathan P. Jackson, Stephen S. Ferguson and Nathan J. Cherrington
Drug Metabolism and Disposition October 1, 2009, 37 (10) 2087-2094; DOI: https://doi.org/10.1124/dmd.109.027466

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
OtherArticle

Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease

Craig D. Fisher, Andrew J. Lickteig, Lisa M. Augustine, James Ranger-Moore, Jonathan P. Jackson, Stephen S. Ferguson and Nathan J. Cherrington
Drug Metabolism and Disposition October 1, 2009, 37 (10) 2087-2094; DOI: https://doi.org/10.1124/dmd.109.027466
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments.
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Determination of Acyl-, O-, and N-Glucuronide
  • TMDD Affects PK of IL-10 Fc-fusion Proteins
  • Uptake as the RDS in Pevonedistat Hepatic Clearance
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics